Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Expression and in Vitro Binding of Protease Activated Receptor1 (PAR1) with Novel Anti-PAR1 Molecules: Data on Fresh Myeloma Marrow Plasma Cells and Human Myeloma Cell Lines

Meral Beksac, MD, Pinar Ataca, MD, Berna Atesagaoglu, MD, Klara Dalva, Andry Nur Hidayat, Ismail Yalcin, Esin Yalcin Aki, Tulin Ozkan, Xenofon Papanikalaou, Saad Z Usmani, MD FACP, Erming Tian, PhD

Blood (2015) 126 (23): 4440.

https://doi.org/10.1182/blood.V126.23.4440.4440

Published: 2015

Journal Articles

Mechanistic Role of HEXIM1 Induction in BRD4-Antagonist Mediated Growth Inhibition, Differentiation and in Vivo Lethal Activity Against Human AML Blast Progenitor Cells

Santhana G. T. Devaraj, PhD, Warren Fiskus, PhD, Bhavin Shah, Sunil Sharma, Jun Qi, PhD, Baohua Sun, MD PhD, Saikat Saha, PhD, Swaminathan Padmanabhan Iyer, MD, Youli Zu, MD PhD, James Bradner, MD, Kapil N. Bhalla, MD

Blood (2014) 124 (21): 3534.

https://doi.org/10.1182/blood.V124.21.3534.3534

Published: 2014

Journal Articles

Structure-Guided Design of A Novel High Affinity Integrin αIIbβ3 Receptor Antagonist (RUC-2) That Displaces Mg 2+ From the β3 MIDAS,

Jieqing Zhu, PhD, Won-Seok Choi, PhD, Joshua G. McCoy, BS, MS, Ana Negri, PhD, Jianghai Zhu, PhD, Sarasija Naini, BS, MS, Jihong Li, MD, Min Shen, PhD, Wenwei Huang, PhD, Craig J. Thomas, PhD, Marta Filizola, PhD, Timothy Springer, PhD, Barry S. Coller, MD

Blood (2011) 118 (21): 3255.

https://doi.org/10.1182/blood.V118.21.3255.3255

Published: 2011

Journal Articles

High Level Production of a Lysosomal Enzyme from HSC-Derived Erythroid Cells for Therapeutic Correction of Hurler Syndrome in Mice.

Daren Wang, PhD, Wei Zhang, MS, Theodosia A. Kalfa, MD, PhD, Punam Malik, MD, Dao Pan, PhD

Blood (2008) 112 (11): 2355.

https://doi.org/10.1182/blood.V112.11.2355.2355

Published: 2008

Journal Articles

Efficacy and Safety of the Gardos Channel Inhibitor, ICA-17043, in Patients with Sickle Cell Anemia.

Kenneth I. Ataga, MBBS, Laura M. DeCastro, MD, Paul Swerdlow, MD, Yogen Saunthararajah, MD, Wally Smith, MD, The ICA-17043 Study Investigators6

Blood (2004) 104 (11): 103.

https://doi.org/10.1182/blood.V104.11.103.103

Published: 2004

Journal Articles

Murine Spherocytosis: Evidence for a Functional Interaction between Protein 4.1 and Na/H Exchange and for a “Protective” Role of the Gardos Channel Against Hemolysis.

Lucia De Franceschi, MD, Alicia Rivera, PhD, Isabel Bize, PhD, Mark Fleming, MD, PHD, Luanne L. Peters, PhD, Philippe Gascard, PhD, Narla Mohandas, PhD, Carlo Brugnara, MD

Blood (2004) 104 (11): 578.

https://doi.org/10.1182/blood.V104.11.578.578

Published: 2004

NARROW

Expression and in Vitro Binding of Protease Activated Receptor1 (PAR1) with Novel Anti-PAR1 Molecules: Data on Fresh Myeloma Marrow Plasma Cells and Human Myeloma Cell Lines

Mechanistic Role of HEXIM1 Induction in BRD4-Antagonist Mediated Growth Inhibition, Differentiation and in Vivo Lethal Activity Against Human AML Blast Progenitor Cells

Structure-Guided Design of A Novel High Affinity Integrin αIIbβ3 Receptor Antagonist (RUC-2) That Displaces Mg 2+ From the β3 MIDAS,

High Level Production of a Lysosomal Enzyme from HSC-Derived Erythroid Cells for Therapeutic Correction of Hurler Syndrome in Mice.

Efficacy and Safety of the Gardos Channel Inhibitor, ICA-17043, in Patients with Sickle Cell Anemia.

Murine Spherocytosis: Evidence for a Functional Interaction between Protein 4.1 and Na/H Exchange and for a “Protective” Role of the Gardos Channel Against Hemolysis.

Email alerts

ASH Publications

American Society of Hematology

Expression and in Vitro Binding of Protease Activated Receptor1 (PAR1) with Novel Anti-PAR1 Molecules: Data on Fresh Myeloma Marrow Plasma Cells and Human Myeloma Cell Lines

Mechanistic Role of HEXIM1 Induction in BRD4-Antagonist Mediated Growth Inhibition, Differentiation and in Vivo Lethal Activity Against Human AML Blast Progenitor Cells

Structure-Guided Design of A Novel High Affinity Integrin αIIbβ3 Receptor Antagonist (RUC-2) That Displaces Mg 2+ From the β3 MIDAS,

High Level Production of a Lysosomal Enzyme from HSC-Derived Erythroid Cells for Therapeutic Correction of Hurler Syndrome in Mice.

Efficacy and Safety of the Gardos Channel Inhibitor, ICA-17043, in Patients with Sickle Cell Anemia.

Murine Spherocytosis: Evidence for a Functional Interaction between Protein 4.1 and Na/H Exchange and for a “Protective” Role of the Gardos Channel Against Hemolysis.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only